Evidence map›Paper›PMID 29721630›Full record

ArticleNeurosurgical review2019

Characteristic features and proposed classification in 69 cases of intracranial microcystic meningiomas.

Zhiqin Lin, Meng Zhao, Xiangrong Li, Junmei Wang, Ping Qiu, Folin Lan, Celin Guan, Dongxia Liao, Dongwei Shen, Jing Lu and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Neurosurgical review, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Zhiqin LinDepartment of Neurosurgery, Longyan First Hospital, Fujian Medical University, Fujian, China.
Meng ZhaoDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, No. 6 TiantanXili, Dongcheng District, Beijing, 100050, China.
Xiangrong LiDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, No. 6 TiantanXili, Dongcheng District, Beijing, 100050, China.
Junmei WangDepartment of Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Ping QiuDepartment of Neurosurgery, Longyan First Hospital, Fujian Medical University, Fujian, China.
Folin LanDepartment of Neurosurgery, Longyan First Hospital, Fujian Medical University, Fujian, China.
Celin GuanDepartment of Neurosurgery, Longyan First Hospital, Fujian Medical University, Fujian, China.
Dongxia LiaoDepartment of Radiotherapy, Longyan First Hospital, Fujian Medical University, Fujian, China.
Dongwei ShenDepartment of Neurosurgery, Longyan First Hospital, Fujian Medical University, Fujian, China.
Jing LuDepartment of Neurosurgery, Longyan First Hospital, Fujian Medical University, Fujian, China.
Shuanglin QueDepartment of Neurosurgery, Longyan First Hospital, Fujian Medical University, Fujian, China.
Zhongli JiangDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, No. 6 TiantanXili, Dongcheng District, Beijing, 100050, China. jiangzhongli5@aliyun.com.ORCID http://orcid.org/0000-0002-0247-423X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microcystic meningioma (MM) is a rare subtype of intracranial meningiomas, with clinical and radiologic features not well characterized in the literature. Based on our experience, we propose a classification system of intracranial MMs. We reviewed the medical records, radiographic studies, and operative notes of a group of consecutive patients with intracranial MM. The mean age of the 69 patients was 46.8 ± 10.6 years (range, 21-75 years). Three types of intracranial MMs could be identified. Type 1 MMs presented as a solid lesion, hypointense or isointense on T1WI, hyperintense on T2WI, and homogeneous or heterogeneous enhancement, and were found in 43 patients (67.2%). Type 2 MMs represented signals similar to CSF both on T1WI and T2WI, and faint reticular enhancement with marginal enhancement, and these were found in 7 patients (10.9%). Type 3 MMs consisted of cystic-solid or cystic lesion and were found in 14 patients (21.9%). Significant differences were observed among the different types of MMs for the following variables: sex, presence of severe peritumoral brain edema (PTBE), and extent of tumor resection. Females were found in all of patients with type 2 MMs, but were only 35.7% of those with type 3 MMs (P = 0.018). Severe PTBEs were more common among patients with type 1 MMs (55.8%) than among those with type 2 (14.3%) and type 3 MMs (14.3%) (P = 0.007). Type 1 MMs (97.7%) were associated with a significantly higher rate of gross total resection compared with the other two types (71.4 and 78.6%) (P = 0.019). Total length of hospital stay after craniotomy ranged from 4 to 30 days (median, 8 days). There were no significant differences in progression-free survival among the three types of MMs (P = 0.788). The current classification identifies three distinct types of intracranial MM based on their radiological findings and growth patterns. The type 1 MMs are more commonly associated with severe PTBE. Type 2 and Type 3 MMs have a higher predilection towards parasaggital location with venous involvement and therefore have a lower rate of gross total resection.

Indexed as

AdultAgedBrain EdemaCraniotomyFemaleHumansMaleMeningeal NeoplasmsMeningiomaMiddle AgedNeoplasm GradingProgression-Free SurvivalRetrospective StudiesTreatment OutcomeYoung AdultClassificationClinical featuresMicrocystic meningiomaRadiology

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.